Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2025)
Historic Debt Ratio for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 0.71.
- Amneal Pharmaceuticals' Debt Ratio rose 334.55% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 334.55%. This contributed to the annual value of 0.68 for FY2024, which is 774.57% down from last year.
- According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Debt Ratio is 0.71, which was up 334.55% from 0.71 recorded in Q2 2025.
- Amneal Pharmaceuticals' 5-year Debt Ratio high stood at 0.74 for Q1 2024, and its period low was 0.67 during Q2 2022.
- Moreover, its 5-year median value for Debt Ratio was 0.7 (2021), whereas its average is 0.7.
- In the last 5 years, Amneal Pharmaceuticals' Debt Ratio surged by 765.74% in 2023 and then tumbled by 774.57% in 2024.
- Quarter analysis of 5 years shows Amneal Pharmaceuticals' Debt Ratio stood at 0.69 in 2021, then rose by 0.81% to 0.7 in 2022, then increased by 5.82% to 0.74 in 2023, then dropped by 7.75% to 0.68 in 2024, then increased by 4.92% to 0.71 in 2025.
- Its Debt Ratio was 0.71 in Q3 2025, compared to 0.71 in Q2 2025 and 0.73 in Q1 2025.